>>13548459very soon
Researchers at Quebec-based biotechnology company Medicago and drugmaker GlaxoSmithKline have developed a plant-based vaccine for SARS-COV-2, the virus that causes COVID-19. And their recently reported interim findings from phase 2 clinical trials look promising. The vaccine uses a plant called Nicotiana benthamiana, which is a relative of the tobacco plant.
Like other COVID-19 vaccines, the plant-based option is a two-dose shot given 21 days apart.1
Results of Medicago’s trials so far showed subjects developed a strong antibody response after receiving the jab—“about 10 times higher than those seen in people recovering from natural disease,” Brian Ward, MD, Medicago’s chief medical officer, tells Verywell.2 “And those antibody [measurements] are higher than almost all of the other vaccines that have been reported to date.”
https://www.verywellhealth.com/plant-based-covid-19-vaccine-canada-5187725 
